According to Amarin Corporation 's latest financial reports and stock price the company's current number of shares outstanding is 408,417,000. At the end of 2023 the company had 408,417,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.40 B | 2.23% |
2022 | 0.39 B | 0.62% |
2021 | 0.39 B | 1.64% |
2020 | 0.39 B | 8.77% |
2019 | 0.35 B | 14.31% |
2018 | 0.31 B | 16.02% |
2017 | 0.27 B | 0.59% |
2016 | 0.26 B | 46.87% |
2015 | 0.18 B | 5% |
2014 | 0.17 B | 2.59% |
2013 | 0.17 B | 14.07% |
2012 | 0.14 B | 11.98% |
2011 | 0.13 B | 33.04% |
2010 | 0.10 B | |
2008 | 17.04 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
AbbVie ABBV | 1,765,940,733 | 332.39% | ๐บ๐ธ USA |
AstraZeneca AZN | 3,098,000,000 | 658.54% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 2,028,000,000 | 396.55% | ๐ฌ๐ง UK |
Alkermes ALKS | 166,607,000 | -59.21% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 174.47% | ๐ฎ๐ฑ Israel |